IDYA - Ideaya Biosciences Inc
IEX Last Trade
39.48
0.310 0.785%
Share volume: 379,125
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$39.17
0.31
0.79%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-08 | 2023-03-07 | 2023-05-09 | 2023-08-10 | 2023-11-07 | 2024-02-20 | 2024-05-07 | |
| Total revenue | 5.851 M | 29.699 M | 4.022 M | 7.880 M | 3.544 M | 8.038 M | 3.923 M | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 5.851 M | 29.699 M | 4.022 M | 7.880 M | 3.544 M | 8.038 M | 3.923 M | 0.000 | |
| 407.59% | -86.46% | 95.92% | -55.03% | 126.81% | -51.19% | -100.00% | |||
| Operating expenses | 28.350 M | 29.039 M | 30.465 M | 34.159 M | 36.253 M | 41.564 M | 45.838 M | 51.017 M | |
| Selling general and admin | 5.554 M | 6.667 M | 5.753 M | 6.300 M | 7.075 M | 7.863 M | 7.068 M | 8.212 M | |
| Research and development | 22.796 M | 22.372 M | 24.712 M | 27.859 M | 29.178 M | 33.701 M | 38.770 M | 42.805 M | |
| Total expenses | 28.350 M | 29.039 M | 30.465 M | 34.159 M | 36.253 M | 41.564 M | 45.838 M | 51.017 M | |
| 2.43% | 4.91% | 12.13% | 6.13% | 14.65% | 10.28% | 11.30% | |||
| Operating income | -22.499 M | 660.000 K | -26.443 M | -26.279 M | -32.709 M | -33.526 M | -41.915 M | -51.017 M | |
| Ebit | -22.499 M | 660.000 K | -26.443 M | -26.279 M | -32.709 M | -33.526 M | -41.915 M | -51.017 M | |
| Pretax income | -22.056 M | 1.615 M | -24.201 M | -23.640 M | -27.926 M | -27.440 M | -33.955 M | -39.572 M | |
| -107.32% | -1,598.51% | -2.32% | 18.13% | -1.74% | 23.74% | 16.54% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -22.056 M | 1.615 M | -24.201 M | -23.640 M | -27.926 M | -27.440 M | -33.955 M | -39.572 M | |
| 107.32% | -1,598.51% | 2.32% | -18.13% | 1.74% | -23.74% | -16.54% | |||
| Net income | -22.056 M | 1.615 M | -24.201 M | -23.640 M | -27.926 M | -27.440 M | -33.955 M | -39.572 M | |
| 107.32% | -1,598.51% | 2.32% | -18.13% | 1.74% | -23.74% | -16.54% |